Medicare

A user ordered a Captain D’s gift card through captainds.com, but it never arrived. The order status on wgiftcard.com shows as pending despite a passed delivery date, and customer service attempts led to unhelpful responses or scams targeting Medicare beneficiaries. The user alleges Captain D’s partnered with a predatory organization called Transaction Wireless.

Roche has discontinued two Huntington’s gene-silencing drugs due to disappointing data. ARPA-H announced a $160 million initiative to accelerate gene-editing therapies for rare diseases. Drugmakers are promoting Medicare’s new obesity drug discount program.

Minnesota will receive over $850,000 from a $36.5 million national settlement with CVS Health Corporation over insulin billing fraud. The settlement addresses CVS's over-billing of government-funded healthcare programs like Medicare and Medicaid.

Washington state's WA Cares program, the nation’s first state-operated long-term care insurance, began distributing benefits in July 2023. Funded by a 0.58% payroll tax surcharge, it offers lifetime benefits of up to $36,500 for those contributing for 10 years. The program aims to address gaps in Medicare and Medicaid coverage for long-term care, with 3.7 million workers participating in 2023.

The use of GLP-1 drugs for weight loss has increased significantly, with 11% of adults currently using them, up from 3% two years ago. Medicare has enabled some patients to access these drugs, potentially driving further adoption.

The Trump administration revealed a 7,100% surge in Medicare claims for skin substitutes over six years and stated that a fraud crackdown prevented millions in fraudulent payments. The increase in claims was uncovered through administrative actions targeting Medicare fraud.

Tamara Johnson spent over $700,000 on long-term care for her mother and husband after they required in-home support due to health issues. She quit her corporate job to care for them, facing financial strain due to a lack of long-term care insurance coverage.

The author recounts a personal fall and a friend's hip injury from an e-bike accident, highlighting the risks of falls among rural elders. Wisconsin has the highest fall-related death rate for adults over 65 in 2023, prompting the author to seek balance programs and address health concerns like orthostatic hypotension and vision issues.

A 29-year-old individual with job-provided insurance receives persistent spam calls offering supplemental Medicare insurance, despite not being enrolled in Medicare. The calls continue even after reporting and blocking numbers, including those using local area codes. The person is on their parents' phone plan, and their parents are nearing Medicare eligibility age.

The article discusses how aging often increases mental burdens for older adults due to health decisions, family responsibilities, and systemic challenges. Experts like Amy O’Rourke and Sam Cradduck suggest strategies such as lowering expectations and intentional energy management to cope. They highlight frustrations with healthcare, technology, and government systems not designed for older adults.

Healthfirst and the Chinese-American Planning Council hosted an event in Manhattan's Chinatown to inform older adults about Medicare and Medicaid plan changes and health resources. The event featured explanations of recent CMS policy updates, wellness activities like a sodium demonstration and chive planting, and bilingual support in English and Chinese.

The article discusses the benefits of whole-body treatment for health, emphasizing that interconnected systems like the gut can impact hormones, metabolism, and immunity. Experts argue that focusing on the body as a unified system, rather than isolated symptoms, may improve outcomes, especially as people age. Challenges include fragmented medical care and Medicare's focus on disease management over holistic approaches.

Dr. Rhea Rogers advocates for a whole-body approach to health, emphasizing interconnected systems like the gut's role in hormonal and immune issues. Experts highlight challenges with aging, including fragmented care and Medicare's focus on disease management over holistic treatment. Patients are urged to advocate for themselves and seek comprehensive solutions.

Dr. Rhea Rogers advocates for whole-body health approaches, arguing that interconnected systems like the gut influence hormonal and immune function. Experts like Amy O’Rourke and Katherine Ambrose highlight systemic barriers in healthcare, such as Medicare's focus on disease management, and urge individuals to advocate for holistic solutions.

Thousands of Medicare beneficiaries enrolled in zero-premium drug plans from Wellcare and other insurers lost coverage after their premiums increased and they failed to pay, leading to termination. Jude Pare, a beneficiary, faced coverage cancellation and potential life-threatening risks due to lost access to critical medication.

The article discusses gaps in Medicare coverage for aging individuals, including caregiving, dental care, and home modifications. It highlights a nonprofit combating loneliness through random acts of social connection and provides tips for caregivers of loved ones with dementia. A couple’s weekly bookstore visits illustrate long-term relationship strategies.

The article highlights four biotech updates: Medicare proposing cuts to 340B payments, Republicans advocating for diversity in clinical trials, former surgeon general Jerome Adams advising on peptides regulation, and Novartis acquiring Myricx Bio for $1.1 billion to expand its cancer drug development. Anthropic CEO Dario Amodei expresses cautious optimism about AI's role in biotechnology.

Advances in healthcare technology and new care delivery models are enabling seniors to age at home, supported by policies like Medicare's Acute Hospital Care at Home program and the GUIDE dementia model. However, home health services face fraud risks, with examples like Los Angeles County's overconcentration of hospice providers and fraudulent billing networks.

Thousands of Medicare beneficiaries lost drug coverage after failing to pay increased premiums they were unaware of, resulting in coverage loss until 2027 due to as little as $8 in unpaid charges.

Thousands of Medicare beneficiaries lost their drug coverage due to small delinquent payments, unaware their zero-dollar premiums had increased. Most cannot regain coverage until 2027.

John Goldstein, a 75-year-old retiree in Newark, New Jersey, spends $150 weekly on groceries by skipping meat and avoiding restaurants to manage rising healthcare costs. He saves money through coupon use, shopping at specific stores like ShopRite, and growing fresh herbs and vegetables at home.

Medicare is now covering some GLP-1 weight loss drugs at a cost of $50 for many older Americans, making these previously expensive medications more affordable.

The U.S. debt, once a masterstroke under Alexander Hamilton's 1790 plan to consolidate Revolutionary War debts, established the nation's creditworthiness and financial power. Today, U.S. debt exceeds $39 trillion, raising concerns over sustainability as interest costs surge and fiscal policies remain unaddressed.

President Donald Trump signed the Big Beautiful Bill Act one year ago, which the Trump administration claims has reduced Medicaid costs and prevented $42 billion in fraudulent health care spending. Democrats argue the law weakens health care programs for low-income Americans, while Dr. Mehmet Oz, administrator of Medicare and Medicaid, defends stricter work requirements and enrollment changes. Estimates suggest over $1 trillion was cut from federal health care spending, with 4.8 million Americans losing Medicaid coverage.

Medicare is now covering some GLP-1 agonists for weight loss at a reduced cost of $50 for eligible older Americans. The federal government began offering these medications to certain Medicare beneficiaries this week, making previously expensive treatments more affordable.

A Prior Auth Bill with wide support and no cost is being considered for passage in Congress. Peggy Tighe of the Regulatory Relief Coalition, a group of physician specialty organizations advocating for reduced Medicare regulatory burdens, expresses hope for the bill's success.

Medicare has initiated a GLP-1 pilot program. The article highlights that Medicare coverage of these weight loss drugs could benefit millions of people.

Medicare proposes reducing payments to hospitals for drugs under the 340B program by over a third, citing surveys showing some patients paid more than hospitals. The change, part of a hospital outpatient payment rule, faces criticism from nonprofit and academic hospital groups, who argue it will harm safety-net providers, as only nonprofit facilities qualify for 340B discounts.

AI could reduce the U.S. deficit by $2.2 trillion by 2036 through productivity gains, but economists warn over half of these savings might be offset by AI-driven disruptions. A study by Brookings and the Federal Reserve highlights potential fiscal benefits from AI but cautions against compounding side effects, similar to the 1990s Internet boom's eroded gains.

The Trump administration proposes a rule to prevent hospitals from charging markups on discounted drugs for Medicare patients, aiming to save $1.1 billion annually. Former CIA Director John Brennan sued the administration over record preservation, while an FBI agent in Chicago resigned amid workforce changes under Director Kash Patel. The American Hospital Association warned the rule could harm hospitals' financial stability.

Medicare is now covering some GLP-1 weight loss drugs for $50, making them more affordable for older Americans. These drugs were previously popular and expensive.

Medicare is now covering some GLP-1 weight loss drugs at a cost of $50, making these previously expensive treatments more affordable for many older Americans.

The Trump administration is proposing a rule to prevent hospitals in the 340B program from billing insurers above discounted drug costs for Medicare patients, aiming to save $1.1 billion annually. The rule targets hospitals that currently markup drug prices, which could reduce patient costs but may also impact hospital revenues and services.

The Trump administration proposes a rule to prevent hospitals in the 340B program from charging markups on discounted drugs for Medicare patients, aiming to save $1.1 billion annually. The rule would adjust Medicare reimbursement formulas for these hospitals, with an example showing potential savings on the prostate cancer drug Lupron Depot.

Medicare will start covering weight-loss drugs via a temporary pilot program on July 1, allowing millions of enrollees access to medications like Wegovy and Zepbound at significantly reduced costs under a deal with Eli Lilly and Novo Nordisk. The program aims to address obesity as a treatable disease, offering seniors like Mary and Jeff Abrahamson affordable options that improve health outcomes.

A new Medicare program may allow coverage for certain weight loss medications, which are currently excluded under existing law. Juliette Cubanski of KFF discusses the potential impact of this change.

Medicare has started covering obesity drugs for the first time, and companies like Walmart and CVS Health are assisting seniors in navigating this coverage.

A Medicare pilot program expands access to GLP-1 weight-loss medications like Wegovy and Zepbound for some seniors, offering subsidies as high as $50 per month. The program, running through 2027, requires a BMI above 35 or specific weight-related conditions for eligibility, though 6 million Medicare Part D recipients who might otherwise qualify will remain excluded. Concerns persist about potential bone and muscle density loss from rapid weight loss, but medical professionals suggest exercise can mitigate risks.

Minnesota counties are overwhelmed by Medicaid renewal bureaucracy due to new federal requirements under HR 1, which mandate shorter reporting cycles and stricter verification. The process has led to unnecessary paperwork for eligible residents, increased administrative costs, and workforce strain in local offices.

The article discusses Medicare's GLP-1 Bridge program, which provides coverage for GLP-1 receptor agonists to manage diabetes and obesity. It aims to address gaps in access to these medications for eligible beneficiaries.